Asian economies are recovering briskly from the global recession, but risks in the region remain, particularly the potential for government policies to slow down growth. Read more..

By ALAN WHEATLEY - International Herald Tribune

An association representing 300 large companies said a provision of the health overhaul would hurt profits. Read more..

By STEVEN GREENHOUSE - The New York Times

One Equity Partners, the private equity arm of JPMorgan Chase, is leading the potential buyout, for about $558 million. Read more..

By BRIAN STELTER and MICHAEL J. de la MERCED - The New York Times

The bond issue is the first borrowing test since the euro zone unveiled a rescue plan. But borrowing costs remained high. Read more..

By DAVID JOLLY - The New York Times

Travel to Mexico, both leisure and business, has been severely affected by drug-war violence, and precautions should be taken to avoid known dangerous areas. Read more..

By JOE SHARKEY - The New York Times

In a ruling with potentially far-reaching implications for the patenting of human genes, a judge struck down a company’s patents on two genes linked to an increased risk of breast and ovarian cancer. Read more..

By JOHN SCHWARTZ and ANDREW POLLACK - The New York Times

A drug giant is about to expand the market for its cholesterol medication, but some experts say that these drugs are not safe as preventive medicine. Read more..

By DUFF WILSON - The New York Times

For the first time, someone outside the family has been given responsibility to run the banking dynasty. Read more..

By JULIA WERDIGIER - International Herald Tribune

The issue of how much money banks need to keep on hand is bound to be on the regulatory front-burner in the near future. Read more..

By ANDREW ROSS SORKIN - The New York Times

The government would earn a profit of about $8 billion if it sold the stake today, on top of $8.1 billion it has already collected. Read more..

By ERIC DASH - The New York Times